AzTrials
AzTrials

Patient SatisfactionNCT07111845

Human Doctors or AI: Evaluating Patient Satisfaction in Urinary Stone Disease Consultations

A study testing Medical Consultation in people with Patient Satisfaction, run by Abant Izzet Baysal University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to understand how satisfied patients are after getting medical advice about urinary stone disease from either a real doctor or an artificial intelligence (AI) chatbot. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Patient Satisfaction
What is being tested?
Medical Consultation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2025to 30 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Newly diagnosed with urinary stone disease,
  • Aged 18 years or older,
  • Provided written informed consent to participate in the study.

Who cannot join

  • History of previous urinary stone disease, stone-related procedures,
  • Presence of other acute medical conditions unrelated to urinary stone disease,
  • Cognitive or communication impairments,
  • Pregnancy.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • İzzet Baysal Eğitim ve Araştırma Hastanesi

    Bolu, 14030

Other trials in Turkey (Türkiye)

About this study

The goal of this observational study is to understand how satisfied patients are after getting medical advice about urinary stone disease from either a real doctor or an artificial intelligence (AI) chatbot. We want to learn whether people feel more satisfied with the information and support they get from human doctors or from AI tools like ChatGPT, Gemini, Perplexity, or Copilot.

The main questions it aims to answer are:

Read more
  • Are patients more satisfied after consulting a real doctor or an AI chatbot?
  • Does the time spent in the consultation affect satisfaction?

Researchers will compare doctor consultations with consultations from different AI chatbots to see if there are differences in patient satisfaction.

Participants will:

  • Ask all their medical questions about urinary stones to one of the sources (a doctor or a specific AI chatbot)
  • Fill out a short questionnaire (CSQ-8) to rate how satisfied they felt with the answers they received
Being tested
Medical Consultation
Keywords
AI in healthcare, chatbot consultations, patient experience, urinary stone disease, digital medicine
Medical subject headings
Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Medical ConsultationBehavioural

    Participants will be randomly assigned to receive medical consultation about urinary stone disease from one of five sources: a real urologist (in-person) or one of four AI chatbots (ChatGPT, Gemini, Perplexity, or Microsoft Copilot). Each participant will be instructed to ask all their questions related to urinary stone disease and continue the consultation until they feel adequately informed. The consultation format (human vs. AI) will depend on group assignment. After the session, participants will complete a validated satisfaction questionnaire (CSQ-8) to assess their experience.

Study groups in NCT07111845
Study groupRoleWhat they receive
Doctors GroupExperimentalParticipants consult a real urologist.
Receives: Behavioral: Medical Consultation
ChatGPT GroupExperimentalParticipants ask all questions to ChatGPT.
Receives: Behavioral: Medical Consultation
Gemini GroupExperimentalParticipants ask all questions to Gemini.
Receives: Behavioral: Medical Consultation
Perplexity GroupExperimentalParticipants ask all questions to Perplexity.
Receives: Behavioral: Medical Consultation
Copilot GroupExperimentalParticipants ask all questions to Microsoft Copilot.
Receives: Behavioral: Medical Consultation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Satisfaction Score

    Patient satisfaction will be measured using the validated Client Satisfaction Questionnaire (CSQ-8), which consists of 8 items scored on a 4-point Likert scale. The total score ranges from 8 to 32, with higher scores indicating greater satisfaction.

    Measured: Within 1 hour after the consultation

Secondary outcomes (1)
  1. Consultation Duration

    Total duration (in minutes) of the consultation session (doctor or chatbot) will be recorded and compared across all groups.

    Measured: During consultation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2025
  2. Study start1 Jan 2025
  3. Primary completion20 May 2025
  4. Study completion30 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07111845
Sponsor's protocol ID
20243209
Status last verified
Aug 2025
First submitted
25 Jul 2025
Last updated
8 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The data generated and analysed during the current study are not publicly available due to ethical and privacy concerns but are available from the corresponding author on reasonable request.

Publications

  • Whiles BB, Bird VG, Canales BK, DiBianco JM, Terry RS. Caution! AI Bot Has Entered the Patient Chat: ChatGPT Has Limitations in Providing Accurate Urologic Healthcare Advice. Urology. 2023 Oct;180:278-284. doi: 10.1016/j.urology.2023.07.010. Epub 2023 Jul 17.

    PubMed 37467806
  • Hanci V, Ergun B, Gul S, Uzun O, Erdemir I, Hanci FB. Assessment of readability, reliability, and quality of ChatGPT(R), BARD(R), Gemini(R), Copilot(R), Perplexity(R) responses on palliative care. Medicine (Baltimore). 2024 Aug 16;103(33):e39305. doi: 10.1097/MD.0000000000039305.

    PubMed 39151545
  • Simon BD, Gelikman DG, Turkbey B. Evaluating the efficacy of artificial intelligence chatbots in urological health: insights for urologists on patient interactions with large language models. Transl Androl Urol. 2024 May 31;13(5):879-883. doi: 10.21037/tau-23-635. Epub 2024 May 7. No abstract available.

    PubMed 38855603
  • Yildiz HA. Human Doctors or AI? Evaluating Patient Satisfaction in Urinary Stone Disease Consultations. J Surg Res. 2026 Jan;317:181-188. doi: 10.1016/j.jss.2025.11.026. Epub 2025 Dec 11.

    PubMed 41385971

Questions about this trial

What is this clinical trial studying?

A study testing Medical Consultation in people with Patient Satisfaction, run by Abant Izzet Baysal University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Satisfaction Score (time frame: Within 1 hour after the consultation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07111845, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in